VCII Stock Overview
ViviCells International, Inc. operates as a stem cell preservation company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ViviCells International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.62% |
| 5 Year Change | -95.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| VCII | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | -3.7% |
| 1Y | n/a | 2.5% | 20.2% |
Return vs Industry: Insufficient data to determine how VCII performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how VCII performed against the US Market.
Price Volatility
| VCII volatility | |
|---|---|
| VCII Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VCII has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VCII's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Kenneth Wulwick | www.vivicells.com |
ViviCells International, Inc. operates as a stem cell preservation company. ViviCells International, Inc. was formerly known as Tropical Beverage Inc. and changed its name to ViviCells International, Inc. in May 2008. The company was incorporated in 1995 and is based in Evanston, Illinois.
ViviCells International, Inc. Fundamentals Summary
| VCII fundamental statistics | |
|---|---|
| Market cap | n/a |
| Earnings (TTM) | -US$436.61k |
| Revenue (TTM) | US$5.09m |
0.0x
P/S Ratio0.0x
P/E RatioIs VCII overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VCII income statement (TTM) | |
|---|---|
| Revenue | US$5.09m |
| Cost of Revenue | US$5.27m |
| Gross Profit | US$1.13m |
| Other Expenses | US$1.57m |
| Earnings | -US$436.61k |
Last Reported Earnings
Sep 30, 2000
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VCII perform over the long term?
See historical performance and comparison